Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4717681 | PMC |
http://dx.doi.org/10.7860/JCDR/2015/15775.7005 | DOI Listing |
Cureus
November 2024
Internal Medicine, Icahn School of Medicine at Mount Sinai, Queens Hospital Center, New York, USA.
Hypercalcemia is a common metabolic complication associated with malignancies, particularly in solid tumors, such as lung and breast cancers. However, its occurrence in hematologic malignancies, including diffuse large B-cell lymphoma (DLBCL), is rare. The pathophysiology of hypercalcemia in lymphomas is often related to the secretion of parathyroid hormone (PTH)-related peptide (PTHrP).
View Article and Find Full Text PDFCase Rep Pediatr
October 2024
Department of Pediatrics, Nepean Hospital, Penrith, New South Wales, Australia.
BMC Endocr Disord
October 2024
Department of Internal Medicine, Yekatit 12 Hospital Medical College, Addis Ababa, Ethiopia.
Cureus
July 2024
Internal Medicine, Sri Ramaswamy Memorial (SRM) Medical College Hospital and Research Center, SRM Institute of Science and Technology (SRMIST), Chengalpattu, IND.
Ann Med Surg (Lond)
July 2024
Faculty of Medicine.
Background: Langerhans cell histiocytosis (LCH) is a rare bone marrow derived neoplasm that mainly affects children. It is a multiorgan disorder and hypothalamic-pituitary involvement is uncommon. LCH reveals a wide spectrum of indications; thus, the diagnosis and treatment are usually challenging.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!